Margaret A T Johnson

Suggest Changes
Learn More
BACKGROUND Pooled analysis of phase 3, double-blind, double-dummy ECHO and THRIVE trials comparing rilpivirine (TMC278) and efavirenz. METHODS Treatment-naive HIV-1-infected adults were randomized(More)